Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
16,102,160
-
Share change
-
-546,850
-
Total reported value
-
$26,032,201
-
Put/Call ratio
-
102%
-
Price per share
-
$1.63
-
Number of holders
-
38
-
Value change
-
-$1,450,114
-
Number of buys
-
19
-
Number of sells
-
24
Institutional Holders of ELOXX PHARMACEUTICALS INC - COM (ELOX) as of Q3 2021
As of 30 Sep 2021,
ELOXX PHARMACEUTICALS INC - COM (ELOX) was held by
38 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
16,102,160 shares.
The largest 10 holders included
VANGUARD GROUP INC, MENORA MIVTACHIM HOLDINGS LTD., AMERICAN FINANCIAL GROUP INC, SILVERARC CAPITAL MANAGEMENT, LLC, Nantahala Capital Management, LLC, Altshuler Shaham Ltd, Altium Capital Management LP, GEODE CAPITAL MANAGEMENT, LLC, TWO SIGMA ADVISERS, LP, and Clal Insurance Enterprises Holdings Ltd.
This page lists
38
institutional shareholders reporting positions in this security
for the Q3 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.